Literature DB >> 29352041

Stress Signaling JNK2 Crosstalk With CaMKII Underlies Enhanced Atrial Arrhythmogenesis.

Jiajie Yan1, Weiwei Zhao1, Justin K Thomson1, Xianlong Gao1, Dominic M DeMarco1, Elena Carrillo1, Biyi Chen1, Xiaomin Wu1, Kenneth S Ginsburg1, Mamdouh Bakhos1, Donald M Bers1, Mark E Anderson1, Long-Sheng Song1, Michael Fill1, Xun Ai2.   

Abstract

RATIONALE: Atrial fibrillation (AF) is the most common arrhythmia, and advanced age is an inevitable and predominant AF risk factor. However, the mechanisms that couple aging and AF propensity remain unclear, making targeted therapeutic interventions unattainable.
OBJECTIVE: To explore the functional role of an important stress response JNK (c-Jun N-terminal kinase) in sarcoplasmic reticulum Ca2+ handling and consequently Ca2+-mediated atrial arrhythmias. METHODS AND
RESULTS: We used a series of cutting-edge electrophysiological and molecular techniques, exploited the power of transgenic mouse models to detail the molecular mechanism, and verified its clinical applicability in parallel studies on donor human hearts. We discovered that significantly increased activity of the stress response kinase JNK2 (JNK isoform 2) in the aged atria is involved in arrhythmic remodeling. The JNK-driven atrial proarrhythmic mechanism is supported by a pathway linking JNK, CaMKII (Ca2+/calmodulin-dependent kinase II), and sarcoplasmic reticulum Ca2+ release RyR2 (ryanodine receptor) channels. JNK2 activates CaMKII, a critical proarrhythmic molecule in cardiac muscle. In turn, activated CaMKII upregulates diastolic sarcoplasmic reticulum Ca2+ leak mediated by RyR2 channels. This leads to aberrant intracellular Ca2+ waves and enhanced AF propensity. In contrast, this mechanism is absent in young atria. In JNK challenged animal models, this is eliminated by JNK2 ablation or CaMKII inhibition.
CONCLUSIONS: We have identified JNK2-driven CaMKII activation as a novel mode of kinase crosstalk and a causal factor in atrial arrhythmic remodeling, making JNK2 a compelling new therapeutic target for AF prevention and treatment.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  aged; atrial fibrillation; calcium-calmodulin-dependent protein kinase type 2; phosphorylation; ryanodine receptor 2; sarcoplasmic reticulum; stress-activated protein kinase JNK2

Mesh:

Substances:

Year:  2018        PMID: 29352041      PMCID: PMC5924593          DOI: 10.1161/CIRCRESAHA.117.312536

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  50 in total

Review 1.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 2.  Inflammation-activated protein kinases as targets for drug development.

Authors:  Michael Karin
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2.

Authors:  D D Yang; D Conze; A J Whitmarsh; T Barrett; R J Davis; M Rincón; R A Flavell
Journal:  Immunity       Date:  1998-10       Impact factor: 31.745

4.  Genetic deletion of Rnd3/RhoE results in mouse heart calcium leakage through upregulation of protein kinase A signaling.

Authors:  Xiangsheng Yang; Tiannan Wang; Xi Lin; Xiaojing Yue; Qiongling Wang; Guoliang Wang; Qin Fu; Xun Ai; David Y Chiang; Christina Y Miyake; Xander H T Wehrens; Jiang Chang
Journal:  Circ Res       Date:  2014-10-27       Impact factor: 17.367

5.  N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.

Authors:  Richard M Angell; Francis L Atkinson; Murray J Brown; Tsu Tshen Chuang; John A Christopher; Maria Cichy-Knight; Allison K Dunn; Kendra E Hightower; Susanna Malkakorpi; James R Musgrave; Margarete Neu; Paul Rowland; Robyn L Shea; Jeffery L Smith; Donald O Somers; Sonia A Thomas; Gladstone Thompson; Ruolan Wang
Journal:  Bioorg Med Chem Lett       Date:  2006-12-15       Impact factor: 2.823

6.  Oxidation of CaMKII determines the cardiotoxic effects of aldosterone.

Authors:  B Julie He; Mei-Ling A Joiner; Madhu V Singh; Elizabeth D Luczak; Paari Dominic Swaminathan; Olha M Koval; William Kutschke; Chantal Allamargot; Jinying Yang; Xiaoqun Guan; Kathy Zimmerman; Isabella M Grumbach; Robert M Weiss; Douglas R Spitz; Curt D Sigmund; W Matthijs Blankesteijn; Stephane Heymans; Peter J Mohler; Mark E Anderson
Journal:  Nat Med       Date:  2011-11-13       Impact factor: 53.440

Review 7.  Protection in the aged heart: preventing the heart-break of old age?

Authors:  Magdalena Juhaszova; Christophe Rabuel; Dmitry B Zorov; Edward G Lakatta; Steven J Sollott
Journal:  Cardiovasc Res       Date:  2005-05-01       Impact factor: 10.787

8.  Suppression of p53-dependent senescence by the JNK signal transduction pathway.

Authors:  Madhumita Das; Feng Jiang; Hayla K Sluss; Chao Zhang; Kevan M Shokat; Richard A Flavell; Roger J Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-24       Impact factor: 11.205

Review 9.  Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac dysfunction.

Authors:  Donald M Bers
Journal:  Annu Rev Physiol       Date:  2013-11-13       Impact factor: 19.318

10.  Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation.

Authors:  Niels Voigt; Jordi Heijman; Qiongling Wang; David Y Chiang; Na Li; Matthias Karck; Xander H T Wehrens; Stanley Nattel; Dobromir Dobrev
Journal:  Circulation       Date:  2013-11-18       Impact factor: 29.690

View more
  28 in total

Review 1.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.

Authors:  Stanley Nattel; Jordi Heijman; Liping Zhou; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Transcriptional regulation of stress kinase JNK2 in pro-arrhythmic CaMKIIδ expression in the aged atrium.

Authors:  Xianlong Gao; Xiaomin Wu; Jiajie Yan; Jingqun Zhang; Weiwei Zhao; Dominic DeMarco; Yongguo Zhang; Mamdouh Bakhos; Gregory Mignery; Jun Sun; Zhenyu Li; Michael Fill; Xun Ai
Journal:  Cardiovasc Res       Date:  2018-04-01       Impact factor: 10.787

3.  Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Postoperative Atrial Fibrillation.

Authors:  Jordi Heijman; Azinwi Phina Muna; Tina Veleva; Cristina E Molina; Henry Sutanto; Marcel Tekook; Qiongling Wang; Issam H Abu-Taha; Marcel Gorka; Stephan Künzel; Ali El-Armouche; Hermann Reichenspurner; Markus Kamler; Viacheslav Nikolaev; Ursula Ravens; Na Li; Stanley Nattel; Xander H T Wehrens; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-07-30       Impact factor: 17.367

4.  Evidence of CaMKII-Regulated Late INa in Atrial Fibrillation Patients With Sleep Apnea: One-Step Closer to Finding Plausible Therapeutic Targets for Atrial Fibrillation?

Authors:  Dan J Bare; Jiajie Yan; Xun Ai
Journal:  Circ Res       Date:  2020-02-27       Impact factor: 17.367

5.  Age-dependent increase in c-Jun N-terminal kinase-2 activity: does this help to understand Ca2+-calmodulin-dependent protein-kinase II-mediated atrial arrhythmogenesis in human atrial fibrillation?

Authors:  Dobromir Dobrev; Kristina Lorenz
Journal:  Cardiovasc Res       Date:  2018-04-01       Impact factor: 10.787

6.  Calmodulin kinase II regulates atrial myocyte late sodium current, calcium handling, and atrial arrhythmia.

Authors:  Amara Greer-Short; Hassan Musa; Katherina M Alsina; Li Ni; Tarah A Word; Julia O Reynolds; Daniel Gratz; Cemantha Lane; Mona El-Refaey; Sathya Unudurthi; Michel Skaf; Ning Li; Vadim V Fedorov; Xander H T Wehrens; Peter J Mohler; Thomas J Hund
Journal:  Heart Rhythm       Date:  2019-10-14       Impact factor: 6.343

7.  Salidroside protects the cardiac function of exhausted rats by inducing Nrf2 expression.

Authors:  Peng Xu; Yang Wang; Weiwei Sun; Yawei Sun; Wei Lu; Yumei Chang; Zheng Ping; Yang Li; Xuebin Cao
Journal:  Cardiovasc J Afr       Date:  2019-10-02       Impact factor: 1.167

Review 8.  The common characteristics and mutual effects of heart failure and atrial fibrillation: initiation, progression, and outcome of the two aging-related heart diseases.

Authors:  Yuxia Pan; Li Xu; Xinchun Yang; Mulei Chen; Yuanfeng Gao
Journal:  Heart Fail Rev       Date:  2021-03-25       Impact factor: 4.214

Review 9.  Serine-threonine protein phosphatase regulation of Cx43 dephosphorylation in arrhythmogenic disorders.

Authors:  Xun Ai; Jiajie Yan; Steven M Pogwizd
Journal:  Cell Signal       Date:  2021-07-02       Impact factor: 4.315

Review 10.  Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations.

Authors:  Dimitrios A Vrachatis; Konstantinos A Papathanasiou; Konstantinos E Iliodromitis; Sotiria G Giotaki; Charalampos Kossyvakis; Konstantinos Raisakis; Andreas Kaoukis; Vaia Lambadiari; Dimitrios Avramides; Bernhard Reimers; Giulio G Stefanini; Michael Cleman; Georgios Giannopoulos; Alexandra Lansky; Spyridon G Deftereos
Journal:  Drugs       Date:  2021-07-23       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.